Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000–2017: Protective effects of non-injecting drug use

Don C. Des Jarlais, K. Arasteh, J. Feelemyer, C. McKnight, David M. Barnes, David C. Perlman, A. Uuskula, H. L.F. Cooper, Susan Tross

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000–2017: Protective effects of non-injecting drug use'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences